Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Aimei Vacin Biopharm (zhejiang) Co., Ltd.

Clinical trials sponsored by Aimei Vacin Biopharm (zhejiang) Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New tetanus vaccine enters first human safety tests Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

New tetanus vaccine enters first human safety tests

Vaccine Ongoing

This early-stage trial is testing a new tetanus vaccine in 80 adults aged 18 and older. The study is randomized and double-blind, meaning neither participants nor doctors know who gets the new vaccine versus an existing one. The main goal is to check for side effects within the f…

Phase 1 • Sponsor: Aimei Vacin BioPharm (Zhejiang) Co., Ltd. • Aim: Vaccine

Last updated Aug 16, 2026 00:00 UTC